Mavyret (glecaprevir/pibrentasvir) / Enanta Pharma, AbbVie  >>  Phase 2
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mavyret (glecaprevir/pibrentasvir) / AbbVie, Enanta Pharma
2015-005004-28: Stratified Treatment OPtimisation for HCV-1 (STOPHCV-1)

Completed
2
408
Europe
Viekirax, Exviera (Dasabuvir), Harvoni, Ribavirin (film-coated 200mg), Ribavirin (hard capsule, 200mg), Ribavirin (film-coated, 400mg), Maviret, Film-coated tablet, , Viekirax, Exviera (Dasabuvir), Harvoni, Maviret
Imperial College London, NIHR Efficacy and Mechanism Evaluation Programme
Hepatitis C Infection (HCV) (genotype 1a/1b/4), Hepatitis C infection, Diseases [C] - Virus Diseases [C02]
 
 
NCT03523871: A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret

Completed
2
20
US
Mavyret, pibrentasvir, glecaprevir
NYU Langone Health
Hepatitis C
09/20
09/20
PURGE-C, NCT04042740: Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection

Completed
2
45
US, RoW
Glecaprevir/Pibrentasvir (G/P), Mavyret
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, AbbVie, National Institute of Allergy and Infectious Diseases (NIAID)
Hepatitis C Infection, HIV Infection
05/23
08/23
THINKER, NCT02743897: Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

Completed
1/2
62
US
Zepatier, Mavyret
University of Pennsylvania, Merck Sharp & Dohme LLC
End Stage Renal Disease
03/22
12/22
NCT04596475: Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor

Completed
1/2
12
US
glecaprevir/pibrentasvir (GLE/PIB)
University of California, San Diego
Hepatitis C, Hepatitis C Virus Infection, Response to Therapy of
04/22
04/22
NCT07040319: Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

Not yet recruiting
1/2
30
US
Glecaprevir/pibrentasvir, GLE/PIB
National Institute of Allergy and Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Mental Health (NIMH), AbbVie
Hepatitis C
07/27
07/27

Download Options